AMERICAN CENTURY COMPANIES INC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 207 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,785,552
-30.0%
474,336
+0.1%
0.01%
-27.3%
Q2 2023$13,985,055
+28.1%
473,909
+0.0%
0.01%
+22.2%
Q1 2023$10,915,960
-16.9%
473,783
+0.3%
0.01%
-18.2%
Q4 2022$13,134,329
-9.4%
472,288
-0.0%
0.01%
-15.4%
Q3 2022$14,497,000
+5.0%
472,374
+0.7%
0.01%
+18.2%
Q2 2022$13,811,000
-20.0%
469,281
-12.5%
0.01%
-8.3%
Q1 2022$17,258,000
-27.8%
536,471
+0.0%
0.01%
-20.0%
Q4 2021$23,918,000
+35.9%
536,282
+53.7%
0.02%
+25.0%
Q3 2021$17,606,000
-23.4%
348,987
+19.2%
0.01%
-25.0%
Q2 2021$22,971,000
+38.1%
292,847
+0.6%
0.02%
+33.3%
Q1 2021$16,630,000
-38.9%
291,242
-10.4%
0.01%
-42.9%
Q4 2020$27,213,000
+82.4%
324,888
-22.0%
0.02%
+61.5%
Q3 2020$14,922,000
+48.2%
416,476
+0.0%
0.01%
+30.0%
Q2 2020$10,067,000
+38.2%
416,346
+0.1%
0.01%
+11.1%
Q1 2020$7,286,000
-2.1%
416,121
-2.6%
0.01%
+28.6%
Q4 2019$7,439,000
-0.2%
427,047
-12.3%
0.01%0.0%
Q3 2019$7,457,000
-26.2%
486,7340.0%0.01%
-30.0%
Q2 2019$10,105,000
+71.8%
486,734
+92.2%
0.01%
+66.7%
Q1 2019$5,881,000253,2940.01%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders